Aspirin

Drug

Drug Profile

Aspirin (acetylsalicylic acid) is a nonsteroidal anti-inflammatory drug used for pain, fever, inflammation, and antithrombotic prevention. It is widely available as an over-the-counter medicine in many jurisdictions and remains one of the most used medicines globally. It also has long-term preventive use in selected cardiovascular patients.

Drug Class
Nonsteroidal anti-inflammatory drug (NSAID)
Approval Status
Marketed medicine with OTC availability in most jurisdictions (US OTC/Rx-only depending on product)
Mechanism of Action
Acts similarly to other NSAIDs and additionally suppresses normal platelet function
Brand Names
  • \Bayer Aspirin\
Indications
  • Pain
  • Fever
  • Inflammation
  • \Antithrombotic prevention of heart attack/stroke in high-risk patients\

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT07613840

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

RECRUITING NA
NCT07597239

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

ACTIVE_NOT_RECRUITING NA
NCT07572747

Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries

NOT_YET_RECRUITING PHASE3
NCT07540416

Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch

NOT_YET_RECRUITING PHASE3
NCT07525635

Aspirin Dosing in Pregnancy

RECRUITING EARLY_PHASE1
NCT07431762

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement

NOT_YET_RECRUITING PHASE4
NCT07373756

Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

NOT_YET_RECRUITING PHASE4
NCT07361679

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

RECRUITING PHASE4
NCT07358416

Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.

ACTIVE_NOT_RECRUITING
NCT07338331

Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

COMPLETED NA